Clinical Research Needs To Move ‘Out Of The Ivory Tower,’ FDA’s Woodcock Urges

 
• By Brenda Sandburg
Sign outside of FDA's headquarters in White Oak, MD
FDA officials advocate moving clinical trials into communities

More from Clinical Trials

More from R&D